Scientists do not have overlapping disease (therapeutic area) interests or expertise and are unable to materially collaborate.
Integration into the process-driven GlobaPharm culture kills the entrepreneurial culture at BioFuture that has been key to its success.
Language barriers severely hinder communication and sharing of information.
Poor management and sense of community as a result of R&D operations that might come with a time difference of 9 hours.
Key scientific talent leaving BioFuture after the acquisition – either because acquisition makes them independently wealthy or because they don't want to be a part of the new big GlobaPharm pharmaco.

Recognize the “human element” of organizational change is always a key component of our work. Don't forget to include these types of insights in your answers.

GlobaPharm Question 4 Reveal